financetom
Business
financetom
/
Business
/
US banks are 'dominant' in European derivatives, EBA says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US banks are 'dominant' in European derivatives, EBA says
Apr 3, 2025 7:52 AM

LONDON (Reuters) - Non-EU banks have carved out "dominant" roles in some of Europe's key financial markets, including derivatives where U.S. banks prevail, the European Banking Authority said on Thursday as concerns about the strategic autonomy of the European financial sector grow.

In its latest deep-dive into the dependence of the EU banking sector on foreign banks and foreign currencies, the EBA - which has a mandate to protect and support the EU financial system - said that U.S. banks had a nearly 28% share of the EU derivatives market at December 2023, consolidating a trend first observed in mid-2021.

Overall, non-EU banks' market share was 33.73%. This heavy presence in derivatives compares with market shares of 8.17% in loans and 6.06% in debt securities, according to the data.

The study was published less than a day after the United States imposed a slew of tariffs on imports, rattling markets and stoking fears of a deep global recession.

Strategic allies and trading partners of the United States are evaluating their reliance on the superpower, their self-sufficiency in financial and military terms, and how they might protect themselves if the uneasy relationship continues to sour.

Some European central banking and supervisory officials are questioning whether they can still rely on the U.S. central bank, Reuters reported last month.

The overall market share of non-EU banks across all assets stands at around 10%, down from around 12% in the previous report, the EBA said.

By currency, 67% of EU/EEA banks' exposures is denominated in euros, 19% is in U.S. dollars, a level which has remained stable since mid-2021, according to the EBA.

"The market shares in certain areas, such as interest rate derivatives, fee income reaped from commodity trading and from providing collective investment services, are substantially higher and are in some cases indicative of dominant roles played by non-EU institutions in the EU banking market," it said.

(Additional reporting by Tommy Reggiori Wilkes;Editing by Elaine Hardcastle)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Upwork Stock Climbs On Strong Q3 Results, Upbeat Guidance
Upwork Stock Climbs On Strong Q3 Results, Upbeat Guidance
Nov 4, 2025
Upwork Inc ( UPWK ) shares are soaring Tuesday after the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above analyst estimates. UPWK is among today’s top performers. See what is driving the movement here. What Happened: Upwork ( UPWK ) reported third-quarter earnings of 36 cents per share, beating the analyst estimate of 29 cents per share by...
--Earnings Flash (QGEN) QIAGEN Posts Q3 Adjusted EPS $0.61, vs. FactSet Est of $0.59
--Earnings Flash (QGEN) QIAGEN Posts Q3 Adjusted EPS $0.61, vs. FactSet Est of $0.59
Nov 4, 2025
01:29 PM EST, 11/04/2025 (MT Newswires) -- Price: 43.91, Change: -1.77, Percent Change: -3.87 ...
Market Chatter: Pfizer Fails to Stop Novo Nordisk's Metsera Bid in Delaware Court
Market Chatter: Pfizer Fails to Stop Novo Nordisk's Metsera Bid in Delaware Court
Nov 4, 2025
01:28 PM EST, 11/04/2025 (MT Newswires) -- Pfizer ( PFE ) and Novo Nordisk's ( NVO ) bidding war to acquire Metsera ( MTSR ) continues as Delaware Chancery Court Judge Morgan Zurn declined to rule on Pfizer's ( PFE ) request that the court temporarily block Novo Nordisk's ( NVO ) bid, Bloomberg reported Tuesday. Pfizer ( PFE )...
Myriad Uranium Upsizes Bought-Deal LIFE Private Placement to $7.5 Million; Shares Down 8%
Myriad Uranium Upsizes Bought-Deal LIFE Private Placement to $7.5 Million; Shares Down 8%
Nov 4, 2025
01:26 PM EST, 11/04/2025 (MT Newswires) -- Myriad Uranium ( MYRUF ) shares fell 8% on Tuesday after it increased the size of a bought-deal private placement to $7.5 million from $6 million. The company is selling an underwriting syndicate 18.8-million units at $0.40 apiece and made up of a share and a three-year warrant to buy a share for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved